Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

High-sensitivity troponin T in preterm infants with a hemodynamically significant patent ductus arteriosus

Abstract

Objective

To investigate if a hemodynamically significant patent ductus arteriosus (hsPDA) leads to elevated high-sensitivity troponin T (hsTnT) and NTproBNP levels in serum.

Study design

Infants <34 weeks and <1500 g were prospectively enrolled, except those with major congenital or chromosomal anomalies. An echocardiogram (ECHO) was performed and hsTnT and NTproBNP were measured within 5 days of life and repeated after treatment of hsPDA. Clinical, ECHO, and hsTnT data were analyzed using Student t-test, two proportion z-test, and regression analysis.

Results

Seventy infants were enrolled. Infants in the hsPDA group had lower gestation and birth weight. Mean hsTnT and NTproBNP levels in the hsPDA group were higher compared to the group without an hsPDA, with levels being 251.54 vs 161.6 pg/ml, p < 0.01 for hsTnT and 18181.02 vs 3149.23 pg/ml, p < 0.001 for NTproBNP.

Conclusion

HsPDA leads to increased hsTnT and NTproBNP levels in preterm infants without affecting cardiac function.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics. 2010;125:1020–30.

    Article  Google Scholar 

  2. Clyman RI. Mechanisms regulating the ductus arteriosus. Biol Neonate. 2006;89:330–5.

    Article  Google Scholar 

  3. Wyllie J. Treatment of patent ductus arteriosus. Semin Neonatol. 2003;8:425–32.

    Article  Google Scholar 

  4. Baylen BG, Ogata H, Oguchi K, Ikegami M, Jacobs H, Jobe A, et al. The contractility and performance of the preterm left ventricle before and after early patent ductus arteriosus occlusion in surfactant-treated lambs. Pediatr Res. 1985;19:1053–8.

    Article  CAS  Google Scholar 

  5. Way GL, Pierce JR, Wolfe RR, McGrath R, Wiggins J, Merenstein GB. ST depression suggesting subendocardial ischemia in neonates with respiratory distress syndrome and patent ductus arteriosus. J Pediatr. 1979;95:609–11.

    Article  CAS  Google Scholar 

  6. McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed. 2007;92:F424–7.

    Article  Google Scholar 

  7. Skeik N, Patel DC. A review of troponins in ischemic heart disease and other conditions. Int J Angiol. 2007;16:53–8.

    Article  Google Scholar 

  8. Sharma S, Jackson PG, Makan J. Cardiac troponins. J Clin Pathol. 2004;57:1025–6.

    Article  CAS  Google Scholar 

  9. Antman E, Bassand J-P, Klein W, Ohman M, Lopez Sendon JL, Rydén L, et al. Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–69.

    Article  Google Scholar 

  10. Makikallio K, Vuolteenaho O, Jouppila P, Rasanen J. Association of severe placental insufficiency and systemic venous pressure rise in the fetus with increased neonatal cardiac troponin T levels. Am J Obstet Gynecol. 2000;183:726–31.

    Article  CAS  Google Scholar 

  11. Szymankiewicz M, Matuszczak-Wleklak M, Hodgman JE, Gadzinowski J. Usefulness of cardiac troponin T and echocardiography in the diagnosis of hypoxic myocardial injury of full-term neonates. Biol Neonate. 2005;88:19–23.

    Article  CAS  Google Scholar 

  12. Trevisanuto D, Zaninotto M, Altinier S, Plebani M, Zanardo V. High serum cardiac troponin T concentrations in preterm infants with respiratory distress syndrome. Acta Paediatr. 2000;89:1134–6.

    Article  CAS  Google Scholar 

  13. Sherwood MW, Kristin Newby L. High-sensitivity troponin assays: evidence, indications, and reasonable use. J Am Heart Assoc. 2014;3:e000403.

    PubMed  PubMed Central  Google Scholar 

  14. Chenevier-Gobeaux C, Bonnefoy-Cudraz E, Charpentier S, Dehoux M, Lefevre G, Meune C, et al. High-sensitivity cardiac troponin assays: answers to frequently asked questions. Arch Cardiovasc Dis. 2015;108:132–49.

    Article  Google Scholar 

  15. Xu RY, Zhu XF, Yang Y, Ye P. High-sensitive cardiac troponin T. J Geriatr Cardiol. 2013;10:102–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. El-Khuffash AF, Molloy EJ. Influence of a patent ductus arteriosus on cardiac troponin T levels in preterm infants. J Pediatr. 2008;153:350–3.

    Article  CAS  Google Scholar 

  17. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92:529–34.

    Article  CAS  Google Scholar 

  18. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82:527–32.

    CAS  PubMed  Google Scholar 

  19. Classification of Retinopathy of Prematurity revisited. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123:991–9.

    Article  Google Scholar 

  20. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187:1–7.

    Article  CAS  Google Scholar 

  21. Jain A, Shah PS. Diagnosis, evaluation, and management of patent ductus arteriosus in preterm neonates. JAMA Pediatr. 2015;169:863–72.

    Article  Google Scholar 

  22. Apple FS. A new season for cardiac troponin assays: it’s time to keep a scorecard. Clin Chem. 2009;55:1303–6.

    Article  CAS  Google Scholar 

  23. Freund Y, Chenevier-Gobeaux C, Bonnet P, Claessens YE, Allo JC, Doumenc B, et al. High-sensitivity versus conventional troponin in the emergency department for the diagnosis of acute myocardial infarction. Crit Care. 2011;15:R147.

    Article  Google Scholar 

  24. Baum H, Hinze A, Bartels P, Neumeier D. Reference values for cardiac troponins T and I in healthy neonates. Clin Biochem. 2004;37:1079–82.

    Article  CAS  Google Scholar 

  25. Clyman RI. The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia. Semin Perinatol. 2013;37:102–7.

    Article  Google Scholar 

  26. Adamcova M, Kokstein Z, Palicka V, Vavrova J, Podholova M, Kost’al M. Cardiac troponin T in neonates after acute and long-term tocolysis. Biol Neonate. 2000;78:288–92.

    Article  CAS  Google Scholar 

  27. Shelton SD, Fouse BL, Holleman CM, Sedor FA, Herbert WN. Cardiac troponin T levels in umbilical cord blood. Am J Obstet Gynecol. 1999;181(5 Pt 1):1259–62.

    Article  CAS  Google Scholar 

  28. Kulkarni M, Gokulakrishnan G, Price J, Fernandes CJ, Leeflang M, Pammi M. Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review. Pediatrics. 2015;135:e510–525.

    Article  Google Scholar 

  29. El-Khuffash AF, Slevin M, McNamara PJ, Molloy EJ. Troponin T, N-terminal pronatriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2011;96:F133–137.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge Catharine White Creech and Lacie Dixon who did the ECHOs of all subjects recruited in the study. The study would not be possible without their help. We would also like to acknowledge all the parents who allowed us to include their infants in the study. We want to acknowledge Roche pharmaceutical (Indianapolis, IN, USA) for their support in the measurement of hsTnT levels.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sunil K. Jain.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest. However, we have received support from Roche Diagnostics, Indianapolis, IN, USA, who provided us with the Elecsys 2010 assay for biomarker analysis for this study, but Roche Diagnostics was not involved in the analysis and interpretation of the research data.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Asrani, P., Aly, A.M., Jiwani, A.K. et al. High-sensitivity troponin T in preterm infants with a hemodynamically significant patent ductus arteriosus. J Perinatol 38, 1483–1489 (2018). https://doi.org/10.1038/s41372-018-0192-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-018-0192-x

This article is cited by

Search

Quick links